Author:
Niu Yingjie,Zhang Fan,Chen Dong,Ye Guolin,Li Yong,Zha Yong,Chen Wenlin,Liu Dequan,Liao Xiaoming,Huang Qinghua,Tang Wei,Cai Gengxi,Guo Rong,Li Hongyang,Tang Shicong
Abstract
AbstractThere are different characteristics of BC in developing countries and developed countries. We intended to study the factors which influence the survival and prognosis of BC between southern China and the United States. (a) To study the two groups BC patients in southern China from 2001 to 2016 and SEER database from 1975 to 2016. (b) To register, collect and analyze the clinicopathological features and treatment information. Our study found that there are significant differences in tumor size, positive lymph node status and KI-67 between southern China and SEER cohort (P < 0.000). The positive lymph node status may be one of the causes of difference of morbidity and mortality of BC patients in China. Furthermore, the differences in treatment methods may also account for the differences between China and seer databases.
Funder
National Natural Science Foundation of China
Scientific Research Foundation of Yunnan Education Department
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Sun, Y. S. et al. Risk factors and preventions of breast cancer. Int. J. Biol. Sci. 13, 1387–1397 (2017).
2. Cha, Y. J., Kim, E. S. & Koo, J. S. Amino acid transporters and glutamine metabolism in breast cancer. Int. J. Mol. Sci. 19, 25 (2018).
3. Zujewski, J. A. et al. Knowledge summaries for comprehensive breast cancer control. J. Glob. Oncol. 4, 1–7 (2018).
4. Melisko, M. E., Gradishar, W. J. & Moy, B. Issues in breast cancer survivorship: Optimal care, bone health, and lifestyle modifications. Am. Soc. Clin. Oncol. Educ. Book. 35, e22-29 (2016).
5. Sun, L., Legood, R., Sadique, Z., Dos-Santos-Silva, I. & Yang, L. Cost-effectiveness of risk-based breast cancer screening programme, China. Bull. World Health Organ. 96, 568–577 (2018).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献